Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Quality Control: SOP for Analyzing Residual Solvents in Injectable Formulations – V 2.0

Posted on By

Quality Control: SOP for Analyzing Residual Solvents in Injectable Formulations – V 2.0

Standard Operating Procedure for Analyzing Residual Solvents in Injectable Formulations


Department Quality Control
SOP No. SOP/QC/167/2025
Supersedes SOP/QC/167/2022
Page No. Page 1 of 15
Issue Date 24/06/2025
Effective Date 26/06/2025
Review Date 24/06/2026

1. Purpose

This SOP describes the procedure for identification and quantification of residual solvents in injectable pharmaceutical formulations using Gas Chromatography (GC). The purpose is to ensure that residual solvent levels comply with regulatory limits as per ICH Q3C guidelines, thereby ensuring

product safety and patient health.

2. Scope

This SOP is applicable to the Quality Control department performing routine testing of residual solvents in raw materials, intermediates, and finished injectable drug products at all stages of production including stability samples.

3. Responsibilities

  • QC Analyst: Prepares samples and standards, operates GC equipment, documents results.
  • QC Supervisor: Reviews analytical data and calculations, approves test results.
  • QA Executive: Verifies the compliance of procedures and reports to applicable standards.
  • Head QC: Ensures method validation, regulatory compliance, and overall procedure adherence.

4. Accountability

The Head of Quality Control is accountable for ensuring this SOP is implemented and followed without deviation, and that all results are scientifically and legally justifiable.

See also  Quality Control: SOP for Handling Out-of-Specification (OOS) Results in QC - V 2.0

5. Procedure

5.1 Classification of Residual Solvents

  • Class 1: Solvents to be avoided (e.g., benzene, carbon tetrachloride).
  • Class 2: Solvents to be limited (e.g., methanol, toluene).
  • Class 3: Solvents with low toxic potential (e.g., ethanol, acetone).

5.2 General Testing Procedure

  1. Prepare standard solutions of residual solvents based on target compounds.
  2. Weigh accurately the sample into a headspace vial and seal with a crimped cap.
  3. Inject samples using a validated Gas Chromatograph equipped with a headspace sampler and flame ionization detector (FID).
  4. Compare retention times and response factors against known standards.
  5. Calculate concentrations using calibration curves or response factors.

5.3 Sample Preparation

  1. Weigh 500 mg of the injectable formulation into a clean headspace vial.
  2. Add a specified volume of solvent (e.g., DMSO or water) as per validated method.
  3. Seal the vial using crimp caps with Teflon-coated septa.
  4. Sonicate for 10 minutes, if necessary, and allow to equilibrate at 60°C for 30 minutes before injection.

5.4 Standard Preparation

  1. Prepare stock solutions of individual solvents in DMSO or water.
  2. Use Class 2 solvents for calibration standards at various concentrations (e.g., 10 ppm, 100 ppm, 500 ppm).
  3. Store all standards under refrigeration and label with expiry dates.
See also  Sterile Injectable Manufacturing: SOP for Cleanroom Pass-Through Equipment Operation - V 2.0

5.5 Instrumental Conditions

  • Column: DB-624 or equivalent
  • Detector: FID
  • Carrier Gas: Nitrogen or Helium
  • Flow Rate: 1.5 mL/min
  • Oven Temp Program: 40°C to 200°C
  • Run Time: 20–30 minutes

5.6 Acceptance Criteria

  • Results must comply with limits outlined in ICH Q3C.
  • Typical limits:
    • Methanol: ≤ 3000 ppm
    • Toluene: ≤ 890 ppm
    • Benzene: Not Detected (ND)
  • Signal-to-noise ratio must be ≥ 10 for the lowest calibration level.

5.7 Documentation and Reporting

  1. Record all data, chromatograms, and calculations in the Residual Solvent Test Report (Annexure-1).
  2. Maintain audit trails and instrument logs.
  3. Review by QC Supervisor and QA before batch disposition.

5.8 Handling OOS Results

  1. Initiate OOS investigation as per SOP/QC/056.
  2. Repeat injection using the same sample preparation to confirm reproducibility.
  3. Perform root cause analysis for deviation.

5.9 Safety Considerations

  • Use PPE: gloves, goggles, and lab coats.
  • Handle Class 1 solvents inside fume hoods.
  • Dispose of organic solvents as per hazardous waste guidelines.
See also  Sterile Injectable Manufacturing: SOP for Reconciliation of Materials Used in Manufacturing - V 2.0

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QC: Quality Control
  • FID: Flame Ionization Detector
  • GC: Gas Chromatography
  • OOS: Out of Specification
  • ICH: International Council for Harmonisation

7. Documents

  1. Residual Solvent Test Report – Annexure-1
  2. Calibration Record Sheet – Annexure-2
  3. Instrument Logbook – Annexure-3

8. References

  • ICH Q3C – Impurities: Residual Solvents
  • USP <467> – Residual Solvents
  • FDA Guidance on Analytical Procedures

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation QC Analyst QA Executive Head QC
Department Quality Control Quality Assurance Quality Control

11. Annexures

Annexure-1: Residual Solvent Test Report

Sample ID Solvent Result (ppm) Limit (ppm) Status
INJ-B154 Methanol 1875 3000 Pass
INJ-B154 Toluene 642 890 Pass

Annexure-2: Calibration Record Sheet

Date Solvent Calibration Range R² Value Performed By
22/06/2025 Methanol 10–5000 ppm 0.9995 Anjali Singh

Annexure-3: Instrument Logbook

Date Instrument ID Activity Analyst
22/06/2025 GC-003 Residual Solvent Analysis Ravi Mehra

Revision History:

Revision Date Revision No. Details Reason Approved By
10/02/2022 1.0 Initial SOP New requirement Head QC
24/06/2025 2.0 Updated for ICH Q3C alignment and annexures Annual review Head QC
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Elixir Department: SOP for Swab Sampling for Cleaning Validation – V 2.0
Next Post: Risks of Using Outdated SOPs Post Regulatory Change in Pharma

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version